Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed
- Wednesday, April 7, 2021, 7:04
- Finance
- Add a comment
MISGAV, Israel, April 7, 2021 /PRNewswire/ — Vvital Biomed Ltd. (“Vvital”), a portfolio company of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), announced the appointment of Ed Rieflin as Chair of the Board. Ed brings 19 years of executive leadership experience and success from…
About the Author
adminasapcorp has written 41785 stories on this site.